MIR3122

Across TCGA pan-cancer cohorts, MIR3122 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated MIR3122 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher MIR3122 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3122 expression acts as an unfavorable survival marker, although some lineages such as CESC and UCS show a favorable association.

KIRP, UCEC, and CHOL are the cancer types where MIR3122 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	All	0.244	0.702	<.001	84	view →
UCEC	DFS	Tertile	All	0.725	0.853	.002	54	view →
CHOL	DFS	Quartile	All	0.121	0.560	.001	53	view →
SKCM	DFS	Tertile	II,III,IV	0.413	0.637	.001	49	view →
BLCA	OS	Quartile	III,IV	0.323	0.502	.028	33	view →
LGG	OS	Tertile	All	0.665	0.834	<.001	33	view →
THCA	DFS	Tertile	All	0.607	0.840	.001	33	view →
CESC	OS	Median	II,III,IV	0.677	0.380	.017	24	view →
PRAD	DFS	Tertile	All	0.689	0.893	.002	24	view →
LUSC	OS	Tertile	IV	0.057	0.786	.017	18	view →
KIRC	DFS	Tertile	All	0.452	0.681	.005	12	view →
UCS	OS	Median	IV	0.693	0.262	.047	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

MIR3122–KIRP (OS)

Open the KIRP breakdown →